Five Prime Therapeutics, Inc.

Alyeska Investment Group, L.P.

Report date

12/31/2020

Quarter

2020 Q4

Filed

2/16/2021

Shares

209,691

Value ($000)

3,567

Weight

0.1%

2013 Q4 - 2020 Q4 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2020 Q4	2/16/2021	3,567	0.1%	209,691	12/31/2020
2013 Q4	2/14/2014	2,139	0.1%	127,401	12/31/2013